Bristol-Myers Squibb (BMY)
$39.66
0.00 (0.00%)
BMY Stock Quote Delayed 30 Minutes
5 Top Stock Trades for Friday: Freeport, Xilinx, Lam Research
Earnings are the big story Friday, so it make sense our top stock trades include Ford, Xilinx, Freeport-McMoran, Bristrol-Myers and more.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
88.13B
PE Ratio
-12.79
EPS
-3.1
Volume (Avg. Vol.)
3,960
Day's Range
-
52-Week Range
$39.35 - $65.38
Dividend & Yield
$2.28 (5.75%)
BMY Stock Predictions, Articles, and Bristol-Myers Squibb News
5 Must-See Stock Charts for Tuesday, Including Roku
Roku soared, while the S&P 500, Twilio, Eli Lilly and Nvidia all perked up as well. Here are a few must-see stock charts for Tuesday.
Bristol-Myers Becomes a Cancer-Fighting Giant With Celgene Buyout
With its Celgene (CELG) buyout, Bristol-Meyers is getting a heck of a deal and will make BMY stock the top-dog cancer medicines.
Friday’s Vital Data: Apple, American Airlines and Bristol-Myers
Options trading was buzzing in Apple, American Airlines and Bristol-Myers Squibb on Thursday. Here are the metrics that matter moving forward.
3 Big Stock Charts for Friday: Incyte, Schlumberger and Abbott Laboratories
The stock charts of INCY, ABT and SLB are set to end the week on a more definitive, trade-worthy footing than most other names.
5 Must-See Stock Charts for Friday: Apple’s Fallout Hits Many
Apple, Celgene and Bristol-Myers made a lot of noise Thursday. Here are a must-see stock charts as a result.
Celgene Stock Surges on Bristol-Myers Mega Deal
Bristol-Myers is taking on the job of bringing Celgene's big pipeline of anti-cancer drugs to the market, and extracting the most value possible from them.
Bristol-Myers Squibb Stock Is Coming Back Slow, but That’s Fine
Bristol-Myers Squibb stock took a hit in October. The stock is still rebounding, albeit slowly which makes it a good value.
5 Best Stocks to Buy Amid the Santa Claus Rally
These names have become stocks to buy as the market has begun to soften its fear. Here's why investors should keep an eye on each.
Why Bristol-Myers Squibb Is a Great Dividend Stock
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Bristol-Myers Squibb (BMY) have what it....
Heat Biologics Stock Is a Worthwhile, Speculative Bet
Heat Biologics has a partnership with Bristol-Myers in developing a cancer drug. If things continue to progress positively, HTBX stock could climb higher.
Why Bristol-Myers Squibb Company Shares Are Down Today
Bristol-Myers Squibb Company (BMY) shares were sliding as the company's collaboration cancer drug with Nektar Therapeutics (NKTR) did not impress investors.
Why Nektar Therapeutics Shares Are Plunging Today
Nektar Therapeutics (NKTR) took a heavy hit on Monday following the release of preliminary results from a recent clinical trial.
Pfizer Inc. Stock Is Boring But Great for Your Portfolio’s Health
Fundamentally PFE is too cheap. So go long on this earnings dip inside a nervous market. Management is proven for decades and is bankable for the future.
Bristol-Myers Squibb Co Reports Earnings for First Quarter of 2018
Bristol-Myers Squibb (BMY) released its earnings report for the first quarter of the year of Thursday and it was a mixed bag.
Stocks Push Forward As Fears of War Diminish
Stocks climbed again on Monday, shrugging off the U.S.-led airstrike on Syria over the weekend. Now the market will get an update on U.S. industrial production as well as a batch of Federal Reserve policymaker speeches.
5 Trades to Make First Thing Tomorrow Morning
On Monday we had be big moves from Bank of America, Starbucks, Ford and others. Here's 5 hot stocks to watch and what trades to make on Tuesday.
Mylan Stock is One Stumble Away From a Big Technical Pullback
Thinking about buying Mylan stock? You may not want to just yet. It's toying with a support line that, if it snaps, could open the selling floodgates.
